S87822 |
Slv320 |
源叶(MedMol) | 98% |
- 产品描述: Derenofylline (SLV 320) is a potent, selective and orally active adenosine A1 receptor antagonist, with Ki values of 1 nM, 200 nM and 398 nM for human A1, A3 and A2A receptors respectively. Derenofylline suppresses cardiac fibrosis and attenuates albuminuria without affecting blood pressure in rats
- 靶点: A1R:1 nM (Ki);Adenosine A3 receptor:200 nM (Ki);A2AR:398 nM (Ki);AdenosineReceptor
- 体内研究:
Derenofylline (0.3-10 mg/kg, oral administration) suppresses adenosine-induced bradycardia in rats. Derenofylline (10 mg/kg/d, oral administration, 12 weeks) reduces myocardial fibrosis in 5/6 nephrectomy rats without affecting blood pressure. Derenofylline (0.1-5mg/kg, intravenous injection) causes no major haemodynamic effects (heart rate and blood pressure). Animal Model: 5/6 nephrectomy rats Dosage: 10 mg/kg/d Administration: Oral administration, mixed with food for 12 weeks Result: Attenuated urinary albuminuria by about 50%.Suppressed the increase in CK levels, ALT and AST plasma levels in nephrectomized animals.
- 参考文献:
1. Kalk P, et al. The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure. Br J Pharmacol. 2007 Aug;151(7):1025-32. 2. Marta Mateus, et al. Understanding the Role of Adenosine Receptors in the Myofibroblast Transformation in Peyronie's Disease. J Sex Med. 2018 Jul;15(7):947-957.
- 溶解性: Soluble in DMSO
- 保存条件: -20℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 3.243 ml 16.214 ml 32.427 ml 5 mM 0.649 ml 3.243 ml 6.485 ml 10 mM 0.324 ml 1.621 ml 3.243 ml 50 mM 0.065 ml 0.324 ml 0.649 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)